A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study. - Concepedia

Concepedia

Publication | Closed Access

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.

370

Citations

24

References

1992

Year

William R. Vogler, E Vélez-García, Roy S. Weiner, Morris A. Flaum, A. A. Bartolucci, G A Omura, M C Gerber, Phillip Banks

Journal of Clinical Oncology

Abstract

This trial demonstrated that IDR was more effective than DNR in remission induction in AML.

References

	Year	Citations

Page 1